GSK Survey Finds Japanese Allergy Patients Willing To Pay ¥330,000 For Treatment
This article was originally published in PharmAsia News
Executive Summary
A survey on allergies conducted by GlaxoSmithKline among business persons in Japan found that patients are willing to pay an average of ¥330,000 to get rid of their symptoms. When asked how much a person was willing to pay if their allergies were cured for life, 70 percent of those surveyed answered between ¥10,000 to ¥500,000, with an average response of ¥330,000. GSK states that the purpose of the survey was to promote allergy prevention and preliminary treatment. (Click for more-Japanese language